Calliditas Therapeutics AB Sponsored ADR Operating Margin 2020-2024 | CALT
Current and historical operating margin for Calliditas Therapeutics AB Sponsored ADR (CALT) over the last 10 years. The current operating profit margin for Calliditas Therapeutics AB Sponsored ADR as of June 30, 2024 is %.
| Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-06-30 | $0.15B | $-0.03B | -22.67% |
| 2024-03-31 | $0.12B | $-0.04B | -30.65% |
| 2023-12-31 | $0.11B | $-0.04B | -30.70% |
| 2023-09-30 | $0.11B | $-0.03B | -29.82% |
| 2023-06-30 | $0.11B | $-0.02B | -19.64% |
| 2023-03-31 | $0.09B | $-0.04B | -38.71% |
| 2022-12-31 | $0.08B | $-0.04B | -51.25% |
| 2022-09-30 | $0.04B | $-0.07B | -173.17% |
| 2022-06-30 | $0.04B | $-0.07B | -171.79% |
| 2021-09-30 | $0.02B | $-0.05B | -221.74% |
| 2020-12-31 | $0.00B | $-0.04B | inf% |
| 2020-03-31 | $0.02B | $-0.01B | -25.00% |
